Confidently advance through the early stages of your product’s development with an experienced partner who understands every step of your drug’s journey to approval.
Meet your critical milestones as we help you prepare your product for IND filing. From documentation to submission, we tailor your experience and help you navigate every step you need to get your product ready to begin trials – from dose selection to study design and analyzing pharmacokinetics data and writing final reports to support IND submissions.
With a deep understanding and expertise in your drug compound, we work closely with you to select the right patients and sites for your first-in-human trials and support dose escalation studies to assure the highest level of patient safety.
We collaborate and share knowledge to inform decisions around dosing as trials move forward, analyze Pharmacokinetics/Pharmacodynamic (PK/PD) relationships to make sure we have optimized doses, and support with strategies for sampling and data analyses.
Our clinical pharmacology package supports your BLA submission and helps you rapidly and accurately respond to regulatory queries. Our team explores exposure/risk balance to inform dose selection decisions for market authorization submissions.
Whether you come to us for full-service end-to-end support or on a single project basis, we support you across a wide range of services to optimize your Early Phase development procedures, including:
Across every stage of your clinical journey, we’re by your side to help you advance through clinical trials to get your therapy to patients and help bring your science to life.
Take your formulation to first-in-human trials and beyond with the support of our team of experts dedicated to the success of your compound.
Explore our news and updates as we liberate the clinical research process.
News
07/22/2024
Events